STOCK TITAN

Palatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

Palatin Technologies, Inc. (NYSE American: PTN) participated in Canaccord Genuity's 40th Annual Growth Conference on August 13, 2020, engaging in a Fireside Chat hosted by John Newman. CEO Carl Spana and CFO Stephen T. Wills represented the company during the virtual event. The discussion focused on Palatin's specialized biopharmaceutical developments, particularly its first-in-class medicines targeting melanocortin and natriuretic peptide receptor systems. A webcast replay is available on the company's website for 90 days.

Loading...
Loading translation...

Positive

  • Participation in a prestigious conference enhances visibility in the biopharmaceutical sector.
  • Engagement with investors via webcast demonstrates transparency and commitment to stakeholder communication.

Negative

  • The lack of new product announcements or clinical trial updates may lead to investor concerns over future growth.
Argus Session date unavailable
+5.73% session move Open Argus
Details

News Market Reaction – PTN

The recorded move for PTN in the trading session of this news was +5.73%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CRANBURY, N.J., Aug. 13, 2020 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, announced that it participated in Canaccord Genuity's 40th Annual Growth Conference in a Fireside Chat today at 10:30 am ET.  The conference was held virtually.

Carl Spana, Ph.D., President and Chief Executive Officer and Stephen T. Wills, Chief Financial Officer and Chief Operating Officer of Palatin Technologies, participated in the Fireside Chat hosted by John Newman of Canaccord Genuity.

The Fireside Chat was webcast.  The webcast replay can be accessed by logging on to the "Investor/Webcasts" section of Palatin's website at http://www.palatin.com or by clicking the following link:  https://wsw.com/webcast/canaccord42/ptn/.  The webcast will be available for 90 days.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.Palatin.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/palatin-technologies-participates-in-canaccord-genuitys-40th-annual-growth-conference-301112185.html

SOURCE Palatin Technologies, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Palatin Technologies discuss at the Canaccord Genuity's 40th Annual Growth Conference?

Palatin Technologies discussed their specialized biopharmaceutical developments and first-in-class medicines targeting melanocortin and natriuretic peptide receptor systems.

Who represented Palatin Technologies at the conference?

Carl Spana, CEO, and Stephen T. Wills, CFO, represented Palatin Technologies during the Fireside Chat.

When did Palatin Technologies participate in the Canaccord Genuity conference?

Palatin Technologies participated in the conference on August 13, 2020, at 10:30 am ET.

Where can I access the webcast of Palatin's Fireside Chat?

The webcast replay can be accessed on Palatin's website under the 'Investor/Webcasts' section.

What is the stock symbol for Palatin Technologies?

The stock symbol for Palatin Technologies is PTN.

Keep reading